In conclusion, we measured renal SGLT2-related excretion at baseline and after short-term SGLT2i treatment in patients with type 2 diabetes using an SGLT2-specific radiotracer and PET scans for the first time. Here, SLC5A2 is linked to type 2 diabetes mellitus.